Tumor immune dysfunction and exclusion (TIDE) is a machine learning tool that uses gene expression data to evaluate T cell dysfunction and exclusion, and to predict tumor responses to anti-PD-1/PD-L1 therapy (6). This evidence concerns the gene CD274 and neoplasm.